Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4092073
Max Phase: Preclinical
Molecular Formula: C45H84Cl7N7O9
Molecular Weight: 860.15
Molecule Type: Small molecule
Associated Items:
ID: ALA4092073
Max Phase: Preclinical
Molecular Formula: C45H84Cl7N7O9
Molecular Weight: 860.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.Cl.Cl.Cl.Cl.Cl.NC[C@H]1O[C@H](O[C@H]2[C@H](OCCCCCCCCCCCCN3CCN(Cc4cccc5ccccc45)CC3)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O
Standard InChI: InChI=1S/C45H77N7O9.7ClH/c46-26-36-35(54)25-34(49)44(58-36)60-41-32(47)24-33(48)42(61-45-40(56)38(50)39(55)37(28-53)59-45)43(41)57-23-12-8-6-4-2-1-3-5-7-11-18-51-19-21-52(22-20-51)27-30-16-13-15-29-14-9-10-17-31(29)30;;;;;;;/h9-10,13-17,32-45,53-56H,1-8,11-12,18-28,46-50H2;7*1H/t32-,33+,34+,35-,36+,37+,38-,39+,40+,41+,42-,43-,44+,45+;;;;;;;/m0......./s1
Standard InChI Key: FCSBRVJYKKSDNN-SOHTTYOASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 860.15 | Molecular Weight (Monoisotopic): 859.5783 | AlogP: 0.60 | #Rotatable Bonds: 22 |
Polar Surface Area: 263.65 | Molecular Species: BASE | HBA: 16 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.66 | CX Basic pKa: 9.75 | CX LogP: 0.88 | CX LogD: -7.51 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.07 | Np Likeness Score: 0.34 |
1. Yang X, Goswami S, Gorityala BK, Domalaon R, Lyu Y, Kumar A, Zhanel GG, Schweizer F.. (2017) A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria., 60 (9): [PMID:28399372] [10.1021/acs.jmedchem.7b00156] |
Source(1):